Sector Chart Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.69 USD | -0.75% |
|
-1.86% | +10.24% |
| 07-20 | Scholar Rock says EU opinion on SMA drug may be pushed to later in 2026 | RE |
| 07-07 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 5.88B | - | - | - | - | - |
| 55.2B | |||||
| 55.6B | |||||
| 23.51B | - | ||||
| 22.35B | - | ||||
| 20.6B |
Select your edition
All financial news and data tailored to specific country editions
